12/19/2025ROCK Inhibitors Beyond IOP: Axonal Regrowth, Perfusion, and NeuroprotectionglaucomaRho kinase inhibitorsneuroprotectionRead Article
12/18/2025Brain Stimulation for Glaucoma: tDCS, TMS, and Visual Cortex Modulationglaucomatranscranial direct current stimulationtranscranial magnetic stimulationRead Article
12/18/2025Circadian Biology, ipRGCs, and Neuroprotection in Glaucomaglaucomacircadian rhythmipRGCRead Article
12/17/2025The 2024–2025 Pipeline for IOP-Independent Neuroprotection in Glaucomaglaucomaneuroprotectionretinal ganglion cellsRead Article
12/17/2025Forecasting Glaucoma Vision Restoration: 5-, 10-, and 20-Year Outlookglaucomavision restorationneuroprotectionRead Article
12/16/2025Nicotinamide and Mitochondrial Rescue: Can Metabolic Therapy Restore Function?glaucomanicotinamideNAD+Read Article
12/16/2025Artificial Vision for End-Stage Glaucoma: Retinal vs. Cortical Prosthesesartificial visionglaucomaretinal implantRead Article
12/15/2025Stem Cell–Derived RGC Transplantation: From Petri Dish to Optic Tractglaucomaretinal ganglion cellsstem cell therapyRead Article
12/15/2025Electrical Stimulation for Glaucoma: Signal Boost or True Neurorestoration?glaucomaelectrical stimulationneuroprotectionRead Article
12/14/2025Gene Therapy for Optic Nerve Regeneration: Modulating PTEN/mTOR, KLFs, and Sox11optic nerve regenerationretinal ganglion cellsPTEN/mTOR pathwayRead Article
